Skip to main content

Remote Job Finders (RJF)

The White House may have struck a deal with Eli Lilly and Novo Nordisk last week to lower the costs of their weight loss drugs for patients, but knockoff versions of Zepbound and Wegovy still permeate the obesity market.
Despite Obesity Drug Pricing Deal, GLP-1 Compounders Continue To Operate in the Shadows
Scroll to top